Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Medicine Corp. Drops on Improved Q1

publication date: May 13, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Medicine Corporation said Q1 revenues rose 43% to $10.1 million while net income rose a more modest 11% to $1.3 million (non-GAAP) or 9 cents per share, fully diluted. A charge related to the fair value of warrants took GAAP earnings down to $.55 million, an eps of 4 cents. Investors were not impressed. Shares of China Medicine fell 17%, slipping 35 cents lower to $1.75 in mid-session. At this price, the company has a market capitalization of just $27 million. More details...

Stock Symbol: (OTCBB: CHME)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners